Various countries are working toward adult-use cannabis legalization to some degree, although none of them are as close as Germany to joining the small group of legalized nations. Germany is aiming to become the first nation in Europe to launch a regulated, for-profit adult-use industry at the national level. Legalization in Germany will usher in a new era of global reform efforts. How likely is it that cannabis storefronts come to Germany in the near future? Will Germany be able to solve the issues regarding EU law and other major problems? And if so, what will legalization in Germany look like? Georg will provide a brief overview and the latest developments.

Germany is the most exciting country on earth right now when it comes to cannabis policy and industry, with German lawmakers currently pursuing the largest adult-use cannabis legalization and regulatory effort in human history. The German Cannabis Business Association (BvCW e.V.) is once again hosting the political discussion panel at ICBC Berlin and has invited members of the German Bundestag from all relevant parties. Panelists will discuss a variety of cannabis political issues, including the development of stimulant regulation, adult-use legalization, medical cannabis policy, commercial hemp, and CBD.

Germany has emerged as a key player in the global medical cannabis market, with a robust regulatory framework and a growing number of patients accessing cannabis for therapeutic use. But Germany is not alone in its pursuit of medical cannabis. Around the world, countries are exploring the potential of cannabis to treat a range of conditions, from chronic pain to epilepsy to cancer. In this panel, experts from Germany and beyond take a closer look at the role of Germany in the medical cannabis industry and to explore the emerging markets and pilot programs around the world. The panel also discusses the critical importance of education for healthcare professionals, patients, and policymakers to ensure the safe and effective use of medical cannabis.

The emerging international cannabis industry is currently governed by a complex web of laws, rules, and regulations that are constantly shifting and evolving. With more countries reforming their cannabis policies and regulations, the regulatory layers will continue to increase in volume for the foreseeable future. Yoram Eshel, CEO of Cannabilog, will present tips and insight regarding how to navigate the ‘regulatory maze’ in an effective way. Eshel will analyze current international supply chain trends, provide an update on regulatory requirements in various markets, and discuss what to anticipate soon. He will also discuss the ‘do’s and don’ts’ when shipping cannabis products worldwide.

The cannabis industry is one of the most heavily regulated industries in the world, with a complex and ever-changing landscape of laws and regulations at the federal, state, and local levels. In this panel, our experts explore the key regulatory and compliance issues facing cannabis businesses today, and discuss best practices for staying on the right side of the law. From licensing and permitting to tax compliance and product safety, they cover the most pressing issues facing the industry and offer insights into how businesses can navigate these challenges.

The cannabis industry is rapidly expanding worldwide, with new markets and production countries emerging at an unprecedented rate. As more and more countries legalize medical and/or recreational cannabis, the opportunities for businesses to tap into these new markets are growing, but so are the challenges. This panel will explore the emerging cannabis sales markets and production countries, the potential for growth and investment, and the unique regulatory and legal considerations that businesses must navigate.

The industrial hemp industry has grown exponentially in recent years, but navigating the regulations surrounding THC content and product standards can be a challenge. From varying THC limits to different regulations for different finished products, the legal landscape for industrial hemp is complex. Different countries have set varying limits on the amount of THC that industrial hemp can contain, ranging from 0.2% to 1%, which can affect the cultivation, processing, and sale of different hemp products. In this panel, experts will explore the patchwork of regulations that apply to industrial hemp, including the different THC limits and product standards, The experts will explore the challenges and opportunities of navigating this regulatory maze and discuss the latest developments in the industry from a regulatory perspective.

When it comes to cannabis, packaging is not just about compliance, it’s about style. From pre-rolls to edibles and everything in between, the right packaging can make all the difference in capturing the attention of your target audience. But with so many options on the market, how do you know which packaging solution is right for you? In this panel, our professionals will explore the latest trends and innovations in cannabis packaging and discuss the relevance of different solutions for the various segments of the industry.

As the cannabis industry continues to grow and evolve, digital technology is poised to play an increasingly important role. From seed-to-sale tracking to customer relationship management, cannabis businesses are turning to software-as-a-service (SaaS) solutions, mobile apps, web 2.0 and big data analytics to improve efficiency, compliance, and customer experience. In this panel, tech specialists will explore the latest trends and opportunities in cannabis technology, and discuss how digital tools can help businesses stay ahead in a rapidly changing industry.

The global drug control policy landscape is shifting rapidly, with many countries and international organizations re-evaluating their approach to cannabis and other drugs. But despite growing support for reform, significant challenges remain, including powerful opposition from entrenched interests and a lack of political will in some areas. In this panel, experienced thought-leaders explore the latest developments in global drug control policy and their implications for the cannabis industry. The panelists discuss the role of lobbying and advocacy in shaping policy reform, and how the cannabis industry can work with policymakers to advance a more rational and humane approach to drug policy.